Moderately bullish activity in Pfizer (PFE), with shares up 56c, or 2.14%, near $26.43. Options volume nearly triple the daily average with 138k contracts traded and calls leading puts for a put/call ratio of 0.31, compared to a typical level near 0.57. Implied volatility (IV30) is higher by 2.4 points near 24.39,and below the 52wk median, suggesting an expected daily move of $0.41. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Pfizer (PFE) will report earnings before the open on 2026-02-03.Option markets are pricing in a 50% probability of a move greater than 2.93% or $0.77.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Pfizer price target raised to $27 from $24 at Cantor Fitzgerald
- Pfizer and BioNTech Move Closer to a Single-Shot Flu–COVID Vaccine: What Investors Should Watch
- Mixed options sentiment in Pfizer with shareslittle changed
- Pfizer’s New Autoimmune Candidate PF-08065010 Enters Phase 1: What Investors Should Watch
- Pfizer Takes Aim at Keytruda in New Phase 3 Lung Cancer Study: What Investors Should Know